M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Is MTHRF a good dividend investment in 2026?
MTHRF offers a 2.46% forward yield with a 50% payout ratio. Strand Safety Score: 78/100 (Safe). The 5-year dividend CAGR of 100% demonstrates strong, consistent growth that outpaces inflation.
MTHRF DRIP calculator β what's the difference?
With DRIP on a $10,000 investment over 10 years, your MTHRF portfolio grows to $13.06M vs $10.74M without reinvestment. This is the compound interest effect in action.
MTHRF dividend growth history & forecast
MTHRF has grown its dividend by 0% over the last year and 100% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 2.46%.
Debt/EBITDA 0.0Γ β low leverage, balance sheet is strong
Earnings Momentum+40.5B β +45.3B β +49.0B
8 / 30 pts
8/30
Net income is positive but trending down β watch for further deterioration
OVERALL ASSESSMENT
Dividend appears safe β fundamentals solid with moderate concerns.
STRAND SCORE
78
/100
Strand Safety Scoreβ’ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
π MTHRF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MTHRF.
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― MTHRF Income Goal & Break-Even
Dividend Break-Even
6yr
Years for dividends to fully repay your MTHRF investment of $11.00/share (πΊπΈ US Taxable (15%) Β· 15.00% tax)
$10K invested Β· 10 Years
Dividends earned (DRIP)
$504.8K
Lost to inflation (2.8% CPI)
β$2.5K
Real purchasing power gain
$502.3K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in MTHRF for:
Shares needed
104,406
Capital required
$1,148,466
Monthly income
$2,000
Based on current dividend of $0.27/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π MTHRF Dividend Payment Schedule
MTHRF pays quarterly β 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
π°
Apr
May
Jun
π°
Jul
Aug
Sep
π°
Oct
Nov
Dec
π°
10 shares
$0.57 / payment
$2.30 / year after tax
100 shares
$5.75 / payment
$22.99 / year after tax
1,000 shares
$57.47 / payment
$229.87 / year after tax
π MTHRF vs Healthcare Benchmarks
How MTHRF compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend YieldβΌ-0.34% vs sectorBelow avg
MTHRF
2.46%
avg
2.80%
5Y Dividend CAGRβ²+93.20% vs sectorBetter
MTHRF
100.00%
avg
6.80%
Payout Ratioβ²-5.00% vs sectorBetter
MTHRF
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MTHRF sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ MTHRF Insider Activity
No recent SEC filings reported in the last 90 days.
π
Next Earnings Report: 2026-04-30(in 30 days)EPS estimate: $0.09
π¬
Financial Health Scores
Altman Z-Score
5.70
β Safe Zone β low bankruptcy risk
Safe: >3.0 Β· Grey: 1.81β3.0 Β· Distress: <1.81
Piotroski F-Score
4/9
β οΈ Moderate fundamentals
Strong: 7β9 Β· Moderate: 4β6 Β· Weak: 0β3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
π About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MTHRF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β